Fibromyalgia or fibromyalgia syndrome (FMS) is a complex chronic pain disorder of unknown causation frequently associated with debilitating fatigue, unrefreshing sleep, cognitive and affective symptoms. A fibromyalgia-type suffering was possibly described in the Book of Job.
three-fold or greater. The American College of Rheumatology criteria for the classification of fibromyalgia was published in 1990 [8] . Since that time (1990) (1991) (1992) (1993) (1994) , PubMed indexing of the specific term "fibromyalgia" steadily increased, whereas "fibrositis" steadily decreased ( Figure   1 ).
Regarding PubMed citations of "arthritis," less than 100 articles were indexed in each 5-year period, from 1910 until the end of WWII. Then, in the decade from 1945-54, the number of publications increased 25-fold from the preceding level (from 64 to 1,551). Since 1955, the numbers of indexed arthritis articles increased circa 30% in each 5-year period, until 2015 (from 1,551 to 30,653). Since 1990, "fibromyalgia" citations have increased about 40% in each 5-year period or even slightly more than "arthritis" (Figure 1 ). The sharply increased trend in numbers of indexed publications on fibromyalgia supports its significance in clinical practice.
-Complexity of fibromyalgia impacting clinical definition and management
Fibromyalgia is a complex and chronic multi-factorial disorder, which will be further defined in other papers of this series. For this historical review, it is characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues, and may be accompanied by headaches, gastrointestinal, and other somatic symptoms. Features usually accumulate gradually over time without an incriminated single triggering event, but may develop after physical trauma or psychological stress. Absence of known causation and its diverse manifestations have led to various treatments. An appreciation of comprehensive physical and Running Head: Person-centered management of fibromyalgia 6 psychological support therapy is developing as well as a person-centered approach to management.
-Categories of treatments indexed in PubMed articles on fibromyalgia
In the total PubMed indexed articles on fibromyalgia (n=8274), treatment was a frequently addressed topic (n=4456), most often related to drug therapies (n=1429), followed by physical (n=1089), behavioral (n=920), sleep (n=764), and exercise (n=646) modalities. Less frequently mentioned therapies are the complementary and alternative medical (CAM) modalities, like acupuncture (n=140), massage (n=77), diet (n=53), and spa therapy (n=39).
Generally speaking, drug therapies are thought to influence the balance of neurochemicals and neurotransmitters that regulate symptoms, such as pain, fatigue, and mood. In contrast, non-drug modalities may more likely influence the fibromyalgia patient's symptom complex through multifaceted pathways, including symptomatic or physical reactivities associated with the person's condition. The evolving practice paradigm for diagnosis and management of FMS favors a person-centered and symptom-based approach using multi-modal therapies best suited to the holistic (integrative medicine) care of the individual patient [9, 10] . As part of this a multimodal approach, drugs may be individualized to treat for pain, mood, and sleep with the goal of mitigating symptoms and restoring function [10] [11] [12] . This review emphasizes the authors' general experiences and literature reports which support the person being the main focus of fibromyalgia management, rather than any particular alteration of behavioral, emotional, or neurophysiologic pathways.
-Classic medical traditions as related to fibromyalgia
Modern practice logistics in care of chronic conditions often involve multiple specialists in management of patients needing enhanced pharmacological, behavioral, cognitive, exercise, physical, and psychological therapies. The challenge is to integrate modern practice logistics, science, and humanism to improve care of individual patients affected by complex disorders.
Sir William Osler stated, "Care more particularly for the individual patient than for the special features of the disease" [13] . Dr. Francis W. Peabody advised Harvard medical school students, "One of the essential qualities of the clinician is interest in humanity, for the secret of the care of the patient is in caring for the patient" [14] . An alternative modern approach to care is to employ "precision medicine" to harness the power of genetic information and other new technology.
Research is needed to determine if a fibromyalgia patient will more likely benefit from an individualized person-centered approach or a precision medicine methodology to discover and treat specific pathways in the disorder. A recent randomized controlled clinical trial investigated the comparative cost-utility of cognitive behavioral therapy (CBT) versus recommended drugs for fibromyalgia patients [15] . A stand-alone CBT intervention was somewhat more costeffective than mainly drug therapy or usual care. Research is needed on the effectiveness and cost-effectiveness of a combined drug and CBT management [10] [11] [12] , rather than either of the investigated treatments alone [15] . The physician's role has considerably evolved over millennia to the present, from the recorded roots in teachings of Ayurveda physicians like Charaka (circa 800 BC) and Hippocrates (circa 460-377 BC) to the present. The ancient medical wisdom and tenets, codified in Charaka and Hippocratic oaths [16, 17] , have guided physicians over the ages [18] . Besides such caring roles, Hippocrates expressed the reward of patient care to physicians, "Where there is love of man, there is also the love of the art" [16] . The medical value of patients' primary data was also longacknowledged, "It is important to ask questions of patients because with the help of these questions one will know more exactly some of the things that concern disease, and one will treat the disease better" Rufus of Ephesus, 1000 AD [19] .
The post-WWII era has contributed great medical and technological advances, but a decreasing focus on the human domain [20] . The biopsychosocial model of care was developed by Dr.
George Libman Engel (1913 Engel ( -1999 , since the late 1970s [20] [21] [22] [23] [24] . He was a psychiatrist and medical pioneer who promoted the extension of the medical bioscience model to include scientific data on the human domain and the person's life circumstances [20] [21] [22] [23] [24] . The essence of this model is to include the patient and his/her attributes as a person, a human being [21] .
Physician's preoccupation with the body and disease could neglect the scientific importance of the patient as a person [21] . Engel [21] and others [25] adapted a "systems view" of health and disease, in which the person is a central component in the organizational hierarchy of interacting and integrated social and organismic levels. Engel [21] advocates that the system level for physicians is always the person, that is the patient, whereas scientists are generally obligated to select one system level or another on which to concentrate. [27] . Further, he indicated that an additional "basic" humanistic science can be developed for the interventions of patient care [26] .
-Holistic concepts of health and disease
The broader concept and framework of human illnesses encouraged a holistic view of medicine (also called wholistic, humanistic, alternative, and consciousness medicine), which has invited numerous professionals and practitioners, besides physicians [28] [29] [30] . The preceding literature supports the importance of person-centered care, especially in a multi-symptomatic condition, as fibromyalgia, in which traditional therapies have had limited efficacy [15, 31] . The scientific challenge is to deal with patients as whole people in their clinical evaluation and care.
A central principle of the holistic concept is that the individual -not the medical care system, not society -is responsible for the development and maintenance of health 
-Holistic concept of health and illness and the biopsychosocial model
An holistic concept of fibromyalgia has personally (ATM) evolved over a five decades clinicalepidemiology career [34] and over three decades collaboration in studies of fibromyalgia [1, 35] .
The classic epidemiological model of agent, host, and environment has proved valuable in deriving a holistic concept of health and illness [29] ). A concept of personalized medicine is an extension of the past century's dominant bioscience or biomedical model [20] . The word 'health'
is derived from an Anglo-Saxon word 'hal' meaning whole and 'heal', which comes from the same root as 'holy' [29] . Consequences of adverse personal, social, and environmental factors on health have been noted since ancient times [36] .
Although, clinical and research advantages of the biopsychosocial model in understanding chronic illnesses have been carefully elucidated [20] [21] [22] [23] [24] , real-life practice logistics have limited its widespread evolution and acceptance. Accordingly, the doctor-patient relationship has not prospered over the past decades. 
-Essential components of the doctor-patient relationship
The doctor-patient relationship has been the continuous core component, if not the historical basis, of medicine and therapy, including Ayurvedic traditions [17] and Hippocratic teachings [41] . The still-needed emphasis on an individual person's conditions has considerably diminished, since the earlier 20 th century by the increasing wave of scientific advances in medical diagnoses and therapy [42] . Defining the patient-physician relationship for the 21 st century is a priority issue in disease management, professional therapists' responsibility, and education [43] [44] [45] .
A good patient-physician relationship is considered "the very heart of healthcare delivery" as it can improve access to care and promote healing [45] . A consensus report on patient-physician relationship indicated 7 principal elements, including: (1) patient self-assessments, (2) access to care, (3) personalizing care, (4) professional education and self-care, (5) integration of information, (6) patient's role in decision-making, and (7) patient-centered and physician-centered outcomes [45] . Favorable patient-centered outcomes included minimizing the disease impact on one's life and the ability to effectively self-manage with confidence. 
-Chronic Care Model (CCM) and Personalized Health Care (PHC) activities
Chronic disease differs from acute episodic disease which may be cured, allowing the patient to return to normal. Chronic disease is continuous, rarely cured, and the patient can live long lives with symptoms from the disease or their behavioral, emotional, and functional consequences [46] . Like primary FMS, "Chronic disease requires a practice of medicine quite different from that used for acute disease," as contrasted by Dr. Halsted Holman [46] . Continuity and integration of care are essential, as is a healing physician-patient relationship in which the patient inevitably becomes a principal caretaker. The patient and physician partnership bring complementary knowledge and reciprocal responsibilities to the care process. An ambulatory chronic care model (CCM) has been formulated, including essential elements of patient and physician roles and integration of education in the process, along with other care resources [46, 47] , as well as a focus on outcomes research effectiveness [48] .
Personalized health care (PCH), including the CCM, is recognized as a potential approach to improve cost-effectiveness in management of a number of chronic diseases, including diabetes, chronic obstructive pulmonary disease, cardiovascular diseases, including chronic heart failure [49, 50] , and rheumatoid arthritis [51] . Further research is encouraged on the elements of such models to improve care, including delivery system design, self-management support, clinical information systems, decision support, and health system organization. The goal is to enhance patient self-management, desirable behavioral changes, and therapeutic decisions favoring disease management [46] [47] [48] [49] [50] [51] .
-Conceptual framework of person-centered management of FMS
Person-centered management of FMS is analogous to a (w)holistic approach to health, both of which broaden the conceptual and therapeutic boundaries as well as understanding limits of the medical model [29, 33, 35] . Health and well-being are also influenced by circumstances or factors outside the medical therapy realm, like socioeconomic status, behavioral and environmental circumstances, and ways of living. All of the preceding factors affect body, mind, and emotional reactivity [52] . 
-Person-centered and patient-centered approaches in care
Person-centered therapy (PCT) had its origin in the humanistic school of psychotherapies developed by Carl Rogers [54] [55] [56] . The therapist's three interrelated core qualifications essential in promoting PCT relations are: (1) willingness to openly relate to clients; (2) convey unconditional positive regard, and (3) achieve an empathetic understanding of the client's This model also encourages patient involvement in self-care. The patient-centered model primarily addresses procedural logistics of care.
-Rationale for a person-centered approach to FMS
Although standard care in FMS has demonstrated some efficacy [31, 58] , lack of understanding of the precise mechanisms that contribute to FMS and the absence of specific biomarkers or brain scan make both conceptualization and systematic assessment of the illness challenging for the health care provider. Such ambiguity can also diminish validity of the patient's illness in health care settings [59] . Because pain and fatigue cannot be objectively visualized, like joint swelling or auscultated like a murmur, their assessment at the current time is based solely on patient self-report. Notably, the assessment of patient-reported symptoms in brief clinical encounters is not as simple as may be supposed. Scant research has been reported on outcomes of person-focused care of FMS patients [9] .
Reasons for the clinical challenge of validating FMS
First, the patient may have endured several years of suffering related to the illness before seeking medical attention [60] . Due to the chronic nature of this illness, persons may have developed maladaptive coping strategies in response to daily suffering, for instance catastrophizing [61] . moderate symptom levels with low anxiety and depression; 3) moderate symptom levels with high anxiety and depression, and 4) high levels of all symptoms. Mood was the most important factor contributing to the subgrouping in the report by Vincent et al [70] , similar to two other studies [65, 67] . However, symptom severity and comorbidities contributed most to the subgrouping in another study [71] . Knowledge of patient subgroups is important, since persons with FMS belonging to different subgroups (clusters) may respond dissimilarly to symptom management programs and pain rehabilitation [72, 73] . Hence, serial assessment of a person's symptom subgroup (cluster) could guide person-centered fibromyalgia care.
Fourth, fibromyalgia patients often have one or more associated chronic conditions that can also impact their complaints. A recent study by Vincent et al [74] demonstrated that over 50% of a community cohort of fibromyalgia patients had seven or more chronic conditions. The most frequent co-morbidities were other pain disorders (chronic joint pain/degenerative arthritis and migraines/chronic headaches), depression, and anxiety. Additionally, over 50% of the cohort met criteria for metabolic syndrome. The presence of fibromyalgia alone is a coping challenge for individual patients, but the symptom burden is greatly amplified when the condition is compounded by psychological and medical comorbidities. Although concurrent assessment and management of comorbidities adds to the complexity of a clinical encounter, it is important in person-centered fibromyalgia care.
Fifth, polypharmacy is commonly reported in fibromyalgia patients and frequently complicates assessment of the clinical pattern. In the study by Vincent et al. [74] , greater than 40% of the community cohort were prescribed three or more medications for fibromyalgia, and greater than 10% were prescribed 5 or more medications. Additionally, 22% of the cohort were prescribed at least one opioid, despite the lack of definitive data supporting such use in fibromyalgia.
Approximately 19% of the cohorts were prescribed benzodiazepines. Although some of these medications may offer symptomatic benefits, adverse effects could contribute to comorbidity.
In summary, the challenge of validation and effective fibromyalgia management is hampered by:
1) chronic nature of the symptoms; 2) psychophysiological burden; 3) complex concurrent presentation of multiple symptoms over time; 4) multiple associated comorbidities, and 5) often polypharmacy, which should optimally be considered when designing a person-centered approach (Figure 2 ).
At this time, a systematic symptom-and person-based assessment has not been reported in fibromyalgia care, although such approach has been critically evaluated [9] . effective, they could also be designed to be delivered in a cost-effective manner.
Several validated questionnaires can be used to help evaluate commonly occurring symptoms [75, 76] . Examples of these questionnaires were recently reviewed [70] This review considers the logistical realities of the primary practitioner or rheumatologist, and is intended to outline the desired scope of FMS management, rather than to direct particular procedural protocols. 
